Championing Liver Health on World Liver Day

The liver is a vital organ responsible for numerous crucial functions in the body, including metabolism, detoxification, and the production of essential proteins. However, viral hepatitis infections, including hepatitis A, B, C, D, and E, affect millions of people worldwide, with hepatitis B and hepatitis C causing chronic infections and disproportionately impacting certain countries.

Insights and Global Advancements on Liver Health

Liver Health

According to the World Health Organization (WHO) estimates in 2019:

  • 296 million people worldwide had hepatitis B.
  • 58 million people worldwide had hepatitis C.
  • There were 1.5 million new cases of chronic hepatitis B infection.
  • There were 1.5 million new cases of chronic hepatitis C infection.
  • Hepatitis B and hepatitis C infections can be lifelong, resulting in 1.1 million deaths in 2019.
  • Hepatitis A and hepatitis E infections, while not chronic, can be severe and lead to liver damage and death. Outbreaks of these infections occur globally, especially in areas with poor sanitation.

Global Progress on Liver Health:

All types of viral hepatitis can be controlled or prevented. Hepatitis C can be cured; most hepatitis C infections can be cured with once-daily oral medication for 8-12 weeks. In 2019, 9.4 million people were undergoing treatment for chronic HCV infection, a more than nine-fold increase since 2015. Medications for treating hepatitis B help prevent liver damage and slow the progression of the disease. Both hepatitis A and hepatitis B can be prevented through safe and effective vaccines. Efforts are underway worldwide to increase the number of children vaccinated against hepatitis B, significantly reducing the incidence of new hepatitis B virus (HBV) infections. Hepatitis A and hepatitis E can also be prevented, and with improved sanitation conditions, cases can be reduced as these infections are transmitted through infected feces between people or through contaminated food and drinking water. These facts underscore the importance of raising awareness about viral hepatitis, promoting vaccination, and implementing effective prevention and treatment strategies to combat liver diseases globally.

Early Detection Saves Lives

Liver Health

Early detection of liver diseases is paramount for effective management and improved patient outcomes. That’s where Artron’s rapid tests come into play. Our HIV, HBsAg & HCV Combo Test are designed to provide quick and accurate results, enabling healthcare professionals to diagnose hepatitis B and hepatitis C infections promptly [3].

The Importance of Early Detection

Improving Treatment Outcomes: Early detection of liver cancer can significantly improve treatment choices and outcomes. When liver cancer is diagnosed early, before it has spread to other organs, it is more likely to be successfully treated. Early-stage liver cancer is more amenable to treatments such as surgery, liver transplantation, or local therapies like radiofrequency ablation.

Enhancing Quality of Life: Early detection can reduce the need for aggressive treatment interventions, thus improving the quality of life for patients. Compared to treatment at later stages, early-stage liver cancer treatment typically has milder side effects and shorter recovery periods.

Prolonging Lifespan: Timely detection and appropriate treatment can extend the lifespan of individuals diagnosed with liver cancer. Early diagnosis provides better opportunities for achieving long-term survival and managing the disease as a chronic condition.

The Power of Rapid Testing on Liver Health:

Artron’s rapid tests offer several advantages, including:

Speed: Results are available within minutes, allowing for immediate diagnosis and timely intervention.

Accuracy: Our tests demonstrate high sensitivity and specificity, ensuring reliable results that healthcare providers can trust.

Convenience: With no need for specialized equipment or laboratory facilities, our rapid tests can be performed in various healthcare settings, including clinics, hospitals, and community outreach programs.

By offering reliable and accessible diagnostic solutions, Artron empowers healthcare providers to screen individuals for hepatitis B and hepatitis C infections efficiently. Early identification of these infections can lead to timely treatment initiation, preventing disease progression and reducing the burden on healthcare systems.

Join Us in Promoting Liver Health

By facilitating early diagnosis and enabling prompt treatment initiation, Artron’s rapid tests play a crucial role in the comprehensive management of liver diseases. Moreover, their user-friendly design and portability make them invaluable tools in various healthcare settings, from hospitals and clinics to remote or resource-limited areas where access to laboratory facilities may be limited.

As we commemorate World Liver Day, Artron Laboratories reaffirms its commitment to advancing liver health through innovation and education. By raising awareness, promoting early detection, and providing accessible testing solutions, we strive to empower individuals and communities to safeguard their liver health and lead healthier lives [4].

References

[1] Global Viral Hepatitis: Millions of People are Affected. (2021, July 19). Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/global/index.htm
[2] World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at: https://www.who.int/publications/i/item/9789240027077external icon.
[3] Draft Global Health Sector Strategies Viral Hepatitis 2016–2021. Available at: https://www.who.int/hepatitis/strategy2016-2021/enexternal icon
[4] Cleveland Clinic medical professional (2022). Cortisol test. Cleveland Clinic. source
[5] GPs’ experiences and perceptions of early detection of liver disease: a qualitative study in primary care. 2018, Sept 25). National Library of Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193778/

 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top